APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI-based Clinical Trial Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI-based Clinical Trial Solution Market Outlook and Growth Opportunities 2026

Report ID 174055820415 January 2026206 pages

Choose your research edition.

Industry ResearchAI-based Clinical Trial Solution Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-based Clinical Trial Solution Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI-based Clinical Trial Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-based Clinical Trial Solution Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-based Clinical Trial Solution Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global AI-based Clinical Trial Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI-based Clinical Trial Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI-based Clinical Trial Solution market include AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies and Mendel.ai, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI-based Clinical Trial Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-based Clinical Trial Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-based Clinical Trial Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-based Clinical Trial Solution market.

AI-based Clinical Trial Solution Segment by Company

AiCure

Antidote

Deep Lens

Saama Technologies

Trials.ai

Deep 6 AI

Innoplexus

Median Technologies

Mendel.ai

Phesi

Tempus

IBM

Digital Reasoning

Insilico Medicine

Insitro

Evotec

PathAI

Cancer Center.ai

AI-based Clinical Trial Solution Segment by Type

Artificial Narrow Intelligence

Artificial General Intelligence

Artificial Super Intelligence

AI-based Clinical Trial Solution Segment by Application

Drug Discovery

Drug Manufacturing

Drug Marketing

Diagnosis and Treatment

Clinical Trials

AI-based Clinical Trial Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI-based Clinical Trial Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI-based Clinical Trial Solution key companies, revenue, market share, and recent developments.

3. To split the AI-based Clinical Trial Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI-based Clinical Trial Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI-based Clinical Trial Solution significant trends, drivers, influence factors in global and regions.

6. To analyze AI-based Clinical Trial Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Clinical Trial Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-based Clinical Trial Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Clinical Trial Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-based Clinical Trial Solution industry.

Chapter 3: Detailed analysis of AI-based Clinical Trial Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI-based Clinical Trial Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI-based Clinical Trial Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI-based Clinical Trial Solution Industry Trends Table 2. AI-based Clinical Trial Solution Industry Drivers Table 3. AI-based Clinical Trial Solution Industry Opportunities and Challenges Table 4. AI-based Clinical Trial Solution Industry Restraints Table 5. Global AI-based Clinical Trial Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI-based Clinical Trial Solution Revenue Share by Company (2021-2026) Table 7. Global AI-based Clinical Trial Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI-based Clinical Trial Solution Key Company Manufacturing Base & Headquarters Table 9. Global AI-based Clinical Trial Solution Company, Product Type & Application Table 10. Global AI-based Clinical Trial Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI-based Clinical Trial Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Artificial Narrow Intelligence Table 15. Significant Companies of Artificial General Intelligence Table 16. Significant Companies of Artificial Super Intelligence Table 17. Global AI-based Clinical Trial Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global AI-based Clinical Trial Solution Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global AI-based Clinical Trial Solution Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global AI-based Clinical Trial Solution Sales Value Share by Type (2021-2026) Table 21. Global AI-based Clinical Trial Solution Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drug Discovery Table 23. Significant Companies of Drug Manufacturing Table 24. Significant Companies of Drug Marketing Table 25. Significant Companies of Diagnosis and Treatment Table 26. Significant Companies of Clinical Trials Table 27. Global AI-based Clinical Trial Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI-based Clinical Trial Solution Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global AI-based Clinical Trial Solution Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global AI-based Clinical Trial Solution Sales Value Share by Application (2021-2026) Table 31. Global AI-based Clinical Trial Solution Sales Value Share by Application (2027-2032) Table 32. Global AI-based Clinical Trial Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI-based Clinical Trial Solution Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global AI-based Clinical Trial Solution Sales Value Share by Region (2021-2026) Table 35. Global AI-based Clinical Trial Solution Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global AI-based Clinical Trial Solution Sales Value Share by Region (2027-2032) Table 37. Global AI-based Clinical Trial Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global AI-based Clinical Trial Solution Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global AI-based Clinical Trial Solution Sales Value Market Share by Country (2021-2026) Table 40. Global AI-based Clinical Trial Solution Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global AI-based Clinical Trial Solution Sales Value Market Share by Country (2027-2032) Table 42. AiCure Company Information Table 43. AiCure Business Overview Table 44. AiCure AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. AiCure AI-based Clinical Trial Solution Product Portfolio Table 46. AiCure Recent Development Table 47. Antidote Company Information Table 48. Antidote Business Overview Table 49. Antidote AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Antidote AI-based Clinical Trial Solution Product Portfolio Table 51. Antidote Recent Development Table 52. Deep Lens Company Information Table 53. Deep Lens Business Overview Table 54. Deep Lens AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Deep Lens AI-based Clinical Trial Solution Product Portfolio Table 56. Deep Lens Recent Development Table 57. Saama Technologies Company Information Table 58. Saama Technologies Business Overview Table 59. Saama Technologies AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Saama Technologies AI-based Clinical Trial Solution Product Portfolio Table 61. Saama Technologies Recent Development Table 62. Trials.ai Company Information Table 63. Trials.ai Business Overview Table 64. Trials.ai AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Trials.ai AI-based Clinical Trial Solution Product Portfolio Table 66. Trials.ai Recent Development Table 67. Deep 6 AI Company Information Table 68. Deep 6 AI Business Overview Table 69. Deep 6 AI AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Deep 6 AI AI-based Clinical Trial Solution Product Portfolio Table 71. Deep 6 AI Recent Development Table 72. Innoplexus Company Information Table 73. Innoplexus Business Overview Table 74. Innoplexus AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Innoplexus AI-based Clinical Trial Solution Product Portfolio Table 76. Innoplexus Recent Development Table 77. Median Technologies Company Information Table 78. Median Technologies Business Overview Table 79. Median Technologies AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Median Technologies AI-based Clinical Trial Solution Product Portfolio Table 81. Median Technologies Recent Development Table 82. Mendel.ai Company Information Table 83. Mendel.ai Business Overview Table 84. Mendel.ai AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mendel.ai AI-based Clinical Trial Solution Product Portfolio Table 86. Mendel.ai Recent Development Table 87. Phesi Company Information Table 88. Phesi Business Overview Table 89. Phesi AI-based Clinical Trial Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Phesi AI-based Clinical Trial Solution Product Portfolio Table 91. Phesi Recent Development Table 92. Tempus Company Information Table 93. Tempus Business Overview Table 94. Tempus AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Tempus AI-based Clinical Trial Solution Product Portfolio Table 96. Tempus Recent Development Table 97. IBM Company Information Table 98. IBM Business Overview Table 99. IBM AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. IBM AI-based Clinical Trial Solution Product Portfolio Table 101. IBM Recent Development Table 102. Digital Reasoning Company Information Table 103. Digital Reasoning Business Overview Table 104. Digital Reasoning AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Digital Reasoning AI-based Clinical Trial Solution Product Portfolio Table 106. Digital Reasoning Recent Development Table 107. Insilico Medicine Company Information Table 108. Insilico Medicine Business Overview Table 109. Insilico Medicine AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Insilico Medicine AI-based Clinical Trial Solution Product Portfolio Table 111. Insilico Medicine Recent Development Table 112. Insitro Company Information Table 113. Insitro Business Overview Table 114. Insitro AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Insitro AI-based Clinical Trial Solution Product Portfolio Table 116. Insitro Recent Development Table 117. Evotec Company Information Table 118. Evotec Business Overview Table 119. Evotec AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Evotec AI-based Clinical Trial Solution Product Portfolio Table 121. Evotec Recent Development Table 122. PathAI Company Information Table 123. PathAI Business Overview Table 124. PathAI AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. PathAI AI-based Clinical Trial Solution Product Portfolio Table 126. PathAI Recent Development Table 127. Cancer Center.ai Company Information Table 128. Cancer Center.ai Business Overview Table 129. Cancer Center.ai AI-based Clinical Trial Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio Table 131. Cancer Center.ai Recent Development Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. AI-based Clinical Trial Solution Product Image Figure 2. Global AI-based Clinical Trial Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global AI-based Clinical Trial Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Artificial Narrow Intelligence Image Figure 8. Artificial General Intelligence Image Figure 9. Artificial Super Intelligence Image Figure 10. Global AI-based Clinical Trial Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global AI-based Clinical Trial Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global AI-based Clinical Trial Solution Sales Value Share by Type (2021-2032) Figure 13. Drug Discovery Image Figure 14. Drug Manufacturing Image Figure 15. Drug Marketing Image Figure 16. Diagnosis and Treatment Image Figure 17. Clinical Trials Image Figure 18. Global AI-based Clinical Trial Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI-based Clinical Trial Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global AI-based Clinical Trial Solution Sales Value Share by Application (2021-2032) Figure 21. Global AI-based Clinical Trial Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global AI-based Clinical Trial Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America AI-based Clinical Trial Solution Sales Value (2021-2032) & (US$ Million) Figure 24. North America AI-based Clinical Trial Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe AI-based Clinical Trial Solution Sales Value (2021-2032) & (US$ Million) Figure 26. Europe AI-based Clinical Trial Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific AI-based Clinical Trial Solution Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific AI-based Clinical Trial Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America AI-based Clinical Trial Solution Sales Value (2021-2032) & (US$ Million) Figure 30. South America AI-based Clinical Trial Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa AI-based Clinical Trial Solution Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa AI-based Clinical Trial Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Narrow Intelligence
  • Artificial General Intelligence
  • Artificial Super Intelligence
Applications
  • Drug Discovery
  • Drug Manufacturing
  • Drug Marketing
  • Diagnosis and Treatment
  • Clinical Trials
Companies covered
  • AiCure
  • Antidote
  • Deep Lens
  • Saama Technologies
  • Trials.ai
  • Deep 6 AI
  • Innoplexus
  • Median Technologies
  • Mendel.ai
  • Phesi
  • Tempus
  • IBM
  • Digital Reasoning
  • Insilico Medicine
  • Insitro
  • Evotec
  • PathAI
  • Cancer Center.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI-based Clinical Trial Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI-based Clinical Trial Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI-based Clinical Trial Solution Market Dynamics
  1. 2.1 AI-based Clinical Trial Solution Industry Trends
  2. 2.2 AI-based Clinical Trial Solution Industry Drivers
  3. 2.3 AI-based Clinical Trial Solution Industry Opportunities and Challenges
  4. 2.4 AI-based Clinical Trial Solution Industry Restraints
3 AI-based Clinical Trial Solution Market by Company
  1. 3.1 Global AI-based Clinical Trial Solution Company Revenue Ranking in 2025
  2. 3.2 Global AI-based Clinical Trial Solution Revenue by Company (2021-2026)
  3. 3.3 Global AI-based Clinical Trial Solution Company Ranking (2024-2026)
  4. 3.4 Global AI-based Clinical Trial Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global AI-based Clinical Trial Solution Company Product Type and Application
  6. 3.6 Global AI-based Clinical Trial Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI-based Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI-based Clinical Trial Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI-based Clinical Trial Solution Market by Type
  1. 4.1 AI-based Clinical Trial Solution Type Introduction
  2. 4.1.1 Artificial Narrow Intelligence
  3. 4.1.2 Artificial General Intelligence
  4. 4.1.3 Artificial Super Intelligence
  5. 4.2 Global AI-based Clinical Trial Solution Sales Value by Type
  6. 4.2.1 Global AI-based Clinical Trial Solution Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global AI-based Clinical Trial Solution Sales Value by Type (2021-2032)
  8. 4.2.3 Global AI-based Clinical Trial Solution Sales Value Share by Type (2021-2032)
5 AI-based Clinical Trial Solution Market by Application
  1. 5.1 AI-based Clinical Trial Solution Application Introduction
  2. 5.1.1 Drug Discovery
  3. 5.1.2 Drug Manufacturing
  4. 5.1.3 Drug Marketing
  5. 5.1.4 Diagnosis and Treatment
  6. 5.1.5 Clinical Trials
  7. 5.2 Global AI-based Clinical Trial Solution Sales Value by Application
  8. 5.2.1 Global AI-based Clinical Trial Solution Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global AI-based Clinical Trial Solution Sales Value by Application (2021-2032)
  10. 5.2.3 Global AI-based Clinical Trial Solution Sales Value Share by Application (2021-2032)
6 AI-based Clinical Trial Solution Regional Value Analysis
  1. 6.1 Global AI-based Clinical Trial Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI-based Clinical Trial Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI-based Clinical Trial Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI-based Clinical Trial Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI-based Clinical Trial Solution Sales Value (2021-2032)
  7. 6.3.2 North America AI-based Clinical Trial Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI-based Clinical Trial Solution Sales Value (2021-2032)
  10. 6.4.2 Europe AI-based Clinical Trial Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI-based Clinical Trial Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI-based Clinical Trial Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI-based Clinical Trial Solution Sales Value (2021-2032)
  16. 6.6.2 South America AI-based Clinical Trial Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI-based Clinical Trial Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI-based Clinical Trial Solution Sales Value Share by Country, 2025 VS 2032
7 AI-based Clinical Trial Solution Country-level Value Analysis
  1. 7.1 Global AI-based Clinical Trial Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI-based Clinical Trial Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI-based Clinical Trial Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI-based Clinical Trial Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI-based Clinical Trial Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI-based Clinical Trial Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI-based Clinical Trial Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AiCure
  2. 8.1.1 AiCure Company Information
  3. 8.1.2 AiCure Business Overview
  4. 8.1.3 AiCure AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AiCure AI-based Clinical Trial Solution Product Portfolio
  6. 8.1.5 AiCure Recent Developments
  7. 8.2 Antidote
  8. 8.2.1 Antidote Company Information
  9. 8.2.2 Antidote Business Overview
  10. 8.2.3 Antidote AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Antidote AI-based Clinical Trial Solution Product Portfolio
  12. 8.2.5 Antidote Recent Developments
  13. 8.3 Deep Lens
  14. 8.3.1 Deep Lens Company Information
  15. 8.3.2 Deep Lens Business Overview
  16. 8.3.3 Deep Lens AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Deep Lens AI-based Clinical Trial Solution Product Portfolio
  18. 8.3.5 Deep Lens Recent Developments
  19. 8.4 Saama Technologies
  20. 8.4.1 Saama Technologies Company Information
  21. 8.4.2 Saama Technologies Business Overview
  22. 8.4.3 Saama Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Saama Technologies AI-based Clinical Trial Solution Product Portfolio
  24. 8.4.5 Saama Technologies Recent Developments
  25. 8.5 Trials.ai
  26. 8.5.1 Trials.ai Company Information
  27. 8.5.2 Trials.ai Business Overview
  28. 8.5.3 Trials.ai AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Trials.ai AI-based Clinical Trial Solution Product Portfolio
  30. 8.5.5 Trials.ai Recent Developments
  31. 8.6 Deep 6 AI
  32. 8.6.1 Deep 6 AI Company Information
  33. 8.6.2 Deep 6 AI Business Overview
  34. 8.6.3 Deep 6 AI AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Deep 6 AI AI-based Clinical Trial Solution Product Portfolio
  36. 8.6.5 Deep 6 AI Recent Developments
  37. 8.7 Innoplexus
  38. 8.7.1 Innoplexus Company Information
  39. 8.7.2 Innoplexus Business Overview
  40. 8.7.3 Innoplexus AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Innoplexus AI-based Clinical Trial Solution Product Portfolio
  42. 8.7.5 Innoplexus Recent Developments
  43. 8.8 Median Technologies
  44. 8.8.1 Median Technologies Company Information
  45. 8.8.2 Median Technologies Business Overview
  46. 8.8.3 Median Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Median Technologies AI-based Clinical Trial Solution Product Portfolio
  48. 8.8.5 Median Technologies Recent Developments
  49. 8.9 Mendel.ai
  50. 8.9.1 Mendel.ai Company Information
  51. 8.9.2 Mendel.ai Business Overview
  52. 8.9.3 Mendel.ai AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mendel.ai AI-based Clinical Trial Solution Product Portfolio
  54. 8.9.5 Mendel.ai Recent Developments
  55. 8.10 Phesi
  56. 8.10.1 Phesi Company Information
  57. 8.10.2 Phesi Business Overview
  58. 8.10.3 Phesi AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Phesi AI-based Clinical Trial Solution Product Portfolio
  60. 8.10.5 Phesi Recent Developments
  61. 8.11 Tempus
  62. 8.11.1 Tempus Company Information
  63. 8.11.2 Tempus Business Overview
  64. 8.11.3 Tempus AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tempus AI-based Clinical Trial Solution Product Portfolio
  66. 8.11.5 Tempus Recent Developments
  67. 8.12 IBM
  68. 8.12.1 IBM Company Information
  69. 8.12.2 IBM Business Overview
  70. 8.12.3 IBM AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 IBM AI-based Clinical Trial Solution Product Portfolio
  72. 8.12.5 IBM Recent Developments
  73. 8.13 Digital Reasoning
  74. 8.13.1 Digital Reasoning Company Information
  75. 8.13.2 Digital Reasoning Business Overview
  76. 8.13.3 Digital Reasoning AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Digital Reasoning AI-based Clinical Trial Solution Product Portfolio
  78. 8.13.5 Digital Reasoning Recent Developments
  79. 8.14 Insilico Medicine
  80. 8.14.1 Insilico Medicine Company Information
  81. 8.14.2 Insilico Medicine Business Overview
  82. 8.14.3 Insilico Medicine AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Insilico Medicine AI-based Clinical Trial Solution Product Portfolio
  84. 8.14.5 Insilico Medicine Recent Developments
  85. 8.15 Insitro
  86. 8.15.1 Insitro Company Information
  87. 8.15.2 Insitro Business Overview
  88. 8.15.3 Insitro AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Insitro AI-based Clinical Trial Solution Product Portfolio
  90. 8.15.5 Insitro Recent Developments
  91. 8.16 Evotec
  92. 8.16.1 Evotec Company Information
  93. 8.16.2 Evotec Business Overview
  94. 8.16.3 Evotec AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Evotec AI-based Clinical Trial Solution Product Portfolio
  96. 8.16.5 Evotec Recent Developments
  97. 8.17 PathAI
  98. 8.17.1 PathAI Company Information
  99. 8.17.2 PathAI Business Overview
  100. 8.17.3 PathAI AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  101. 8.17.4 PathAI AI-based Clinical Trial Solution Product Portfolio
  102. 8.17.5 PathAI Recent Developments
  103. 8.18 Cancer Center.ai
  104. 8.18.1 Cancer Center.ai Company Information
  105. 8.18.2 Cancer Center.ai Business Overview
  106. 8.18.3 Cancer Center.ai AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio
  108. 8.18.5 Cancer Center.ai Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst